We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Inspire Investor Challenges $430M Merck Deal

Law360 (April 12, 2011, 5:30 PM EDT) -- A shareholder slapped Inspire Pharmaceuticals Inc. with a class action in Delaware on Monday, claiming a proposed $430 million sale to Merck & Co. Inc. undervalues the company.

Named plaintiff Anthony...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.